Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-25-000132

Director bought 30,000 shares at $6.86 ($205,797)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BARABE TIMOTHY C Director 2025-12-04 Purchase +30,000 $6.86 $205,797 54,366 D
Open-market purchases · 30,000 sh · avg $6.86 · $205,797
Loading xslF345X05/wk-form4_1765228029.xml…